je.st
news
Tag: therapeutics
Mirati Therapeutics Reports Second Quarter 2013 Financial Results
2013-08-13 05:30:49| Appliances - Topix.net
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today! San Diego, California, August 12, 2013 - Mirati Therapeutics, Inc. today reported financial results for the second quarter and first six months ended June 30, 2013.
Tags: results
reports
financial
quarter
Insider Selling: Anika Therapeutics Director Sells 26,984 Shares of Stock
2013-08-10 05:41:05| Biotech - Topix.net
Anika Therapeutics Director Steve Wheeler unloaded 26,984 shares of the stock in a transaction that occured on Thursday, August 8th.
Tags: stock
director
selling
shares
Ensemble Therapeutics And Alexion Initiate Collaboration To Discover Macrocycle Drug Candidates Targeting Patients With Severe And Ultra-Rare Disorders
2013-07-18 09:30:00| drugdiscoveryonline Home Page
Ensemble Therapeutics, a biotechnology company developing Ensemblins, a novel class of small molecule therapeutics with the potential to modulate targets typically addressed by biologics, recently announced the initiation of a drug discovery collaboration with a subsidiary of Alexion Pharmaceuticals, Inc., the global biopharmaceutical company focused on developing and commercializing life-transforming therapies for patients with life-threatening, ultra-rare disorders
Tags: drug
discover
patients
collaboration
Paladin Labs Acquires Allon Therapeutics
2013-07-17 21:32:51| Agriculture - Topix.net
Paladin Labs, Inc. has acquired Allon Therapeutics in accordance with the Order for Reorganization in Allon's proposal proceedings under Canada's Bankruptcy and Insolvency Act and Business Corporations Act, becoming the sole shareholder of Allon.
Tags: labs
acquires
therapeutics
paladin
Mirati Therapeutics to Commence Trading on the
2013-07-16 01:15:49| Appliances - Topix.net
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today! San Diego, California, July 15, 2013 - Mirati Therapeutics Inc. today announced that the NASDAQ Capital Market has informed the Company that its common stock will commence trading on the NASDAQ beginning today, July 15, 2013 under the ticker symbol MRTX.
Tags: the
trading
commence
therapeutics
Sites : [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] next »